Atevirdine

DB12264InvestigationalSmall molecule

Atevirdine has been used in trials studying the treatment of HIV Infections.

Mechanism: Pharmacologically active on Reverse transcriptase/RNaseH
Curator reviewed
Formula / weight: C₂₁H₂₅N₅O₂ · 379.464 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyUCPOMLWZWRTIAA-UHFFFAOYSA-NSMILESCCNC1=CC=CN=C1N1CCN(CC1)C(=O)C1=CC2=CC(OC)=CC=C2N1

Targets

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Atevirdine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.